Arachidonic acid, eicosanoids, and fracture repair

Journal of Orthopaedic Trauma

Volumn 24, Issue 9, 2010, Pages 539-542

  Wixted, John J ^a   Fanning, Paul ^a   Rothkopf, Ian ^a   Stein, Gary ^b   Lian, Jane ^b  

^a Department of Orthopedic Surgery ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

5 LO; arachidonic acid; bone; cartilage; cys LTR1; fracture; leukotriene

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; ICOSANOID; LEUKOTRIENE B4; LEUKOTRIENE DERIVATIVE; MONTELUKAST; PROSTAGLANDIN DERIVATIVE; ZILEUTON;

BONE REMODELING; CALLUS; CARTILAGE CELL; CARTILAGE FRACTURE; ENZYME INHIBITION; FRACTURE; FRACTURE HEALING; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW;

ANIMALS; ARACHIDONIC ACID; CARTILAGE, ARTICULAR; CHONDROGENESIS; EICOSANOIDS; FRACTURE HEALING; FRACTURES, BONE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES;

EID: 77956243116     PISSN: 08905339     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOT.0b013e3181f17b33     Document Type: Review

References (18)

1. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem. 2003;88:873-884.
2. Kanakaris NK, Paliobeis C, Nlanidakis N, et al. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury. 2007;38(Suppl 2):S65-S75.
3. Iwakura T, Miwa M, Sakai Y, et al. Human hypertrophic nonunion tissue contains mesenchymal progenitor cells with multilineage capacity in vitro. J Orthop Res. 2009;27:208-215.
4. Fajardo M, Liu CJ, Egol K. Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study. Clin Orthop Relat Res. 2009;467:3071-3078.
5. Kayal RA, Tsatsas D, Bauer MA, et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res. 2007;22: 560-568.
6. Kokubu T, Haudenschild DR, Moseley TA, et al. Immunolocalization of IL-17A, IL-17B, and their receptors in chondrocytes during fracture healing. J Histochem Cytochem. 2008;56:89-95.
7. Abdul-Hadi O, Parvizi J, Austin MS, et al. Nonsteroidal anti-inflammatory drugs in orthopaedics. J Bone Joint Surg Am. 2009;91:2020-2027.
8. Brown KM, Saunders MM, Kirsch T, et al. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am. 2004;86:116-123.
9. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop. 2005;76:470-474.
10. Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med.2008;14:461-469.
11. Riccioni G, Capra V, D'Orazio N, et al. Leukotriene modifiers in the treatment of cardiovascular diseases. J Leukoc Biol. 2008;84:1374-1378.
12. Back M. Gamma-glutamyltransferase, leukotrienes, and cardiovascular risk. Eur Heart J. 2007;28:269.
13. Genovese T, Rossi A, Mazzon E, et al. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol. 2008;153:568-582.
14. Talahalli R, Zarini S, Sheibani N, et al. Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:1699-1708.
15. Traianedes K, Dallas MR, Garrett IR, et al. 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology. 1998;139:3178-3184.
16. Manigrasso MB, O'Connor JP. Accelerating Fracture Repair by Manipulating Arachidonic Acid Metabolism. 52nd Annual Meeting of the Orthopaedic Research Society; March 19-22, 2006. Chicago, IL.
17. Wixted JJ, Fanning PJ, Gaur T, et al. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: a novel role of the cysteinyl LT-1 receptor. J Cell Physiol. 2009;221:31-39.
18. Cottrell JA, O'Connor JP. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J Bone Joint Surg Am. 2009; 91:2653-2665.